NIPD Genetics: Clinical and COVID-19 tests will be performed at the clinical sample collection centers of NIPD Genetics
The temporary COVID-19 sample collection sites stationed in stadium parking lots will move their operations to the NIPD Genetics clinical sample collection centers
On Saturday, the 5th of June 2021, the temporary PCR and rapid antigen COVID-19 sample collection sites stationed in stadium parking lots will be moving their operations to the clinical sample collection centers of NIPD Genetics, throughout Cyprus.
All COVID-19 related tests, as well as all the clinical laboratories tests will be carried out at the NIPD Genetics’ clinical sample collection centers. The moving of the temporary sample collection sites will allow for better and faster service towards the public. The operating hours for COVID-19 testing are from 7:00 to 18:00 on weekdays and 7:00 to 13:00 on weekends. Results will be available on the same or following day, depending on the time of the sample collection.
Sample collection centers
Nicosia, Egkomi, 31 Neas Egkomis, 2409 – Tel: 22267890
Nicosia, Lakatamia, 80 Arch. Makariou III, 2323 – Tel: 22267891
Nicosia, Latsia, 25 Arch. Makariou III, 2220 – Tel: 22267893
Nicosia, Platy, 143CD Kyrenias Avenue, 2113 – Tel: 22267892
Limassol, Agios Athanasios, 20 Kolonakiou, 4103 – Tel: 22267898
Limassol, Limassol city center, 64 Agias Fylaxeos, 3025 – Tel: 22267897
Larnaca, Larnaca city center, 18 Zakinthou, 6018 – Tel: 22267895
Larnaca, Athienou, Agiou Georgiou, 7600 – Tel: 22267894
Ammochostos, Paralimni, 14 Agiou Georgiou, 5280 – Tel: 22267896
*Paphos, Stelios Kyriakides Stadium (former Pafiako), Democracy Avenue – Tel: 77 77 77 30
For more information on the locations and contact details of the clinical sample collection centers of NIPD Genetics please visit www.nipdlabs.com.cy .
* The hours of operation of Stelios Kyriakides stadium (former Pafiako) for the weekdays are 07:00 - 15:00 and weekends 07:00 - 13:00.
NIPD GENETICS MOLECULAR LABORATORIES
NIPD Genetics Molecular Laboratories is a leading innovative biotechnology company active in the field of developing, engineering, and providing in vitro genetic testing solutions through its extensive portfolio of prenatal, reproductive, oncological, neonatal, cardiovascular, and metabolic genetic tests. NIPD Genetics laboratories are accredited by CAP and certified by CLIA and ISO standards. NIPD Genetics applies its proprietary genetic and bioinformatic analysis tools to develop novel tests and technologies for prognosis, prevention of genetic diseases, better clinical management, and therapy.